SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Idenix Pharmaceuticals (IDIX)
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
412 15 0 IDIX
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
37<i>If nvs is paying for all of 283 and telbivudine and that's all thatDewDiligence_on_SI-5/2/2006
36If nvs is paying for all of 283 and telbivudine and that's all that's inrkrw-5/2/2006
35Idenix Pharmaceuticals Reports First Quarter Financial Results Guidance is thaDewDiligence_on_SI-5/2/2006
34My two cents on the NM283 PR: investorshub.comDewDiligence_on_SI-4/29/2006
33Favorable Antiviral Activity and Improved Tolerability Demonstrated by ValopicitLJM-4/29/2006
32VX 950 is also 3/day.rkrw-4/20/2006
31SGP Updates Status of HCV Program: urlcut.comDewDiligence_on_SI-4/20/2006
30Notes on the PJ report (corrected link): tinyurl.comDewDiligence_on_SI-4/5/2006
29Notes on the PJ report: tinyurl.com p.s. I added shares today at 12.26.DewDiligence_on_SI-4/5/2006
28Musings on IDIX investment rationale: investorshub.comDewDiligence_on_SI-4/2/2006
27Idenix Provides Update on Clinical Development of Valopicitabine (NM283) for thezeta1961-3/23/2006
26Idenix Announces Thirteen Data Presentations at the 2006 European Association fotnsaf-3/17/2006
25U.S. Food and Drug Administration for Telbivudine for the Treatment of LJM-1/3/2006
24"This is just all off the top of my head. It is pretty shallow... kind of lgodfodder-12/16/2005
23You may wish to start at one of the clinic trial website and see if you can stilkenhott-12/14/2005
22Is the control arm "undetectable" levels of 19% high? It strikes me asgodfodder-12/14/2005
21Off the top of my head, investors are probably disappointed with the undetectablkenhott-12/14/2005
20Highly anticipated 12 and 24 week data for NM283 and PIII meeting with FDA . .tuck-12/14/2005
19Charly of MF on IDIX: fool.com Cheers, Tucktuck-4/19/2005
18>>PARIS, April 14 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (tuck-4/14/2005
17>>SAN FRANCISCO, Calif., Jan. 10 /PRNewswire-FirstCall/ -- Idenix Pharmacetuck-1/10/2005
16no message..zeta1961-10/22/2004
15>>CAMBRIDGE, Mass., Oct. 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticatuck-10/12/2004
14Press Release Source: Valeant Pharmaceuticals Valeant Pharmaceuticals to Preserkrw-10/1/2004
13Thanks, rkrw -- that's exactly what I wanted to find out! Best, BobThe Dodgy Ticker-9/27/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News